Xellia is a company headquartered in Denmark. Brouky records 4 investors associated with the company.
Xellia is a global pharmaceutical company specializing in the production of fermentation-based non-beta-lactam anti-infective active pharmaceutical ingredients (APIs) and finished dosage forms, supplying over 500 pharmaceutical companies in 80 countries.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.